Cell Culture - Drug Delivery Co-Op
Vancouver, British Columbia, Canada
- Designed, formulated, and tested mRNA lipid nanoparticles (LNPs) using microfluidic technology for vaccine applications.
- Successfully maintained human embryonic kidney 293 cell line (HEK293) daily to ensure viability and health.
- Developed and characterized novel lipid-based nanoparticle formulations packaged with mRNA in vitro.
- Performed cell-based experiments with HEK293 cells to determine the biological activity of lipid nanoparticles in vitro.
- Supported the development and optimization of new cell-based assays to enhance efficiency and efficacy.
- Delivered findings to the R&D team through presentations and prepared guidelines for future co-op students.